Integrative Genomics Analysis of Genes with Biallelic Loss and Its Relation to the Expression of MRNA and Micro-RNA in Esophageal Squamous Cell Carcinoma

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2015 Sep 28

PMID 26409826

Citations 21

Authors

Nan Hu

Chaoyu Wang

Robert J Clifford

Howard H Yang

Hua Su

Lemin Wang

Yuan Wang

Yi Xu

Ze-Zhong Tang

Ti Ding

Tongwu Zhang

Alisa M Goldstein

Carol Giffen

Maxwell P Lee

Philip R Taylor

Affiliations

Soon will be listed here.

Abstract

Background: Genomic instability plays an important role in human cancers. We previously characterized genomic instability in esophageal squamous cell carcinomas (ESCC) in terms of loss of heterozygosity (LOH) and copy number (CN) changes in tumors. In the current study we focus on biallelic loss and its relation to expression of mRNA and miRNA in ESCC using results from 500 K SNP, mRNA, and miRNA arrays in 30 cases from a high-risk region of China.

Results: (i) Biallelic loss was uncommon but when it occurred it exhibited a consistent pattern: only 77 genes (<0.5%) showed biallelic loss in at least 10% of ESCC samples, but nearly all of these genes were concentrated on just four chromosomal arms (i.e., 42 genes on 3p, 14 genes on 9p, 10 genes on 5q, and seven genes on 4p). (ii) Biallelic loss was associated with lower mRNA expression: 52 of the 77 genes also had RNA expression data, and 41 (79%) showed lower expression levels in cases with biallelic loss compared to those without. (iii) The relation of biallelic loss to miRNA expression was less clear but appeared to favor higher miRNA levels: of 60 miRNA-target gene pairs, 34 pairs (57%) had higher miRNA expression with biallelic loss than without, while 26 pairs (43%) had lower miRNA expression. (iv) Finally, the effect of biallelic loss on the relation between miRNA and mRNA expression was complex. Biallelic loss was most commonly associated with a pattern of elevated miRNA and reduced mRNA (43%), but a pattern of both reduced miRNA and mRNA was also common (35%).

Conclusion: Our results indicate that biallelic loss in ESCC is uncommon, but when it occurs it is localized to a few specific chromosome regions and is associated with reduced mRNA expression of affected genes. The effect of biallelic loss on miRNA expression and on the relation between miRNA and mRNA expressions was complex.

Citing Articles

ESRRG-PKM2 axis reprograms metabolism to suppress esophageal squamous carcinoma progression and enhance anti-PD-1 therapy efficacy.

Wang T, Zhu Y, Chen L, Zhang W, Qi H, Shi X J Transl Med. 2023; 21(1):605.

PMID: 37679788 PMC: 10485992. DOI: 10.1186/s12967-023-04347-5.

Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma.

Zhang Y, Chen K, Wang L, Chen J, Lin Z, Chen Y Aging (Albany NY). 2023; 15(17):8993-9021.

PMID: 37665670 PMC: 10522377. DOI: 10.18632/aging.205012.

Identifying liver metastasis-related hub genes in breast cancer and characterizing as a potential prognostic biomarker.

Chen M, Zheng W, Fang L PeerJ. 2023; 11:e15311.

PMID: 37180578 PMC: 10174054. DOI: 10.7717/peerj.15311.

Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling: Characterization, therapeutic targets, and prognostic value.

Wang D, Dai J, Suo C, Wang S, Zhang Y, Chen X Front Genet. 2022; 13:1033214.

PMID: 36425064 PMC: 9678939. DOI: 10.3389/fgene.2022.1033214.

Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma.

Hu N, Wang C, Zhang T, Su H, Liu H, Yang H Cancers (Basel). 2022; 14(20).

PMID: 36291785 PMC: 9599939. DOI: 10.3390/cancers14205001.

References

Mestre-Escorihuela C, Rubio-Moscardo F, Richter J, Siebert R, Climent J, Fresquet V . Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood. 2006; 109(1):271-80. DOI: 10.1182/blood-2006-06-026500. View

Tamoto E, Tada M, Murakawa K, Takada M, Shindo G, Teramoto K . Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res. 2004; 10(11):3629-38. DOI: 10.1158/1078-0432.CCR-04-0048. View

Patnaik S, Mallick R, Yendamuri S . MicroRNAs and esophageal cancer. J Gastrointest Oncol. 2012; 1(1):55-63. PMC: 3397565. DOI: 10.3978/j.issn.2078-6891.2010.011. View

Sulong S, Moorman A, Irving J, Strefford J, Konn Z, Case M . A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood. 2008; 113(1):100-7. DOI: 10.1182/blood-2008-07-166801. View

Mosca L, Fabris S, Lionetti M, Todoerti K, Agnelli L, Morabito F . Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion. Clin Cancer Res. 2010; 16(23):5641-53. DOI: 10.1158/1078-0432.CCR-10-0151. View

Hu N, Wang C, Ng D, Clifford R, Yang H, Tang Z . Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res. 2009; 69(14):5908-17. PMC: 2734334. DOI: 10.1158/0008-5472.CAN-08-4622. View

Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. DOI: 10.3322/caac.20073. View

Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X . Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 2008; 68(1):26-33. DOI: 10.1158/0008-5472.CAN-06-4418. View

Parkin D, Bray F, Ferlay J, Pisani P . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108. DOI: 10.3322/canjclin.55.2.74. View

10.

Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson E . Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010; 28(4):341-7. PMC: 2852471. DOI: 10.1038/nbt.1618. View

11.

Hu N, Wang C, Han X, He L, Tang Z, Giffen C . Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer. Oncogene. 2003; 23(3):852-8. DOI: 10.1038/sj.onc.1207150. View

12.

Nancarrow D, Handoko H, Smithers B, Gotley D, Drew P, Watson D . Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res. 2008; 68(11):4163-72. DOI: 10.1158/0008-5472.CAN-07-6710. View

13.

Hu N, Huang J, Emmert-Buck M, Tang Z, ROTH M, Wang C . Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res. 2001; 7(4):883-91. View

14.

Yang L, Parkin D, Ferlay J, Li L, Chen Y . Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005; 14(1):243-50. View

15.

Lord C, Ashworth A . The DNA damage response and cancer therapy. Nature. 2012; 481(7381):287-94. DOI: 10.1038/nature10760. View

16.

Hu N, Clifford R, Yang H, Wang C, Goldstein A, Ding T . Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics. 2010; 11:576. PMC: 3091724. DOI: 10.1186/1471-2164-11-576. View

17.

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

18.

Su H, Hu N, Yang H, Wang C, Takikita M, Wang Q . Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin Cancer Res. 2011; 17(9):2955-66. PMC: 3086948. DOI: 10.1158/1078-0432.CCR-10-2724. View

19.

Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad I . Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012; 44(6):694-8. PMC: 3819251. DOI: 10.1038/ng.2256. View

20.

Hu N, Wang C, Su H, Li W, Emmert-Buck M, Li G . High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high-risk Chinese population. Genes Chromosomes Cancer. 2004; 39(3):205-16. DOI: 10.1002/gcc.10315. View